CS Diagnostics Corp. (CSDX)
0.0105
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
CS Diagnostics Net Income (Quarterly) : 0.0391M for Dec. 31, 2025
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.0391M |
| September 30, 2025 | -0.0002M |
| June 30, 2025 | 0.0002M |
| March 31, 2025 | 0.0321M |
| December 31, 2024 | -0.0127M |
| September 30, 2024 | 0.0005M |
| June 30, 2024 | 0.0043M |
| March 31, 2024 | 0.0086M |
| December 31, 2023 | -0.1225M |
| September 30, 2023 | 0.0182M |
| June 30, 2023 | 0.0582M |
| March 31, 2023 | 0.024M |
| December 31, 2022 | 0.0109M |
| September 30, 2022 | -0.0019M |
| June 30, 2022 | -0.0019M |
| March 31, 2022 | -0.0019M |
| September 30, 2015 | -0.0056M |
| June 30, 2015 | -0.004M |
| Date | Value |
|---|---|
| March 31, 2015 | -0.0047M |
| December 31, 2014 | -0.037M |
| September 30, 2014 | 0.0225M |
| June 30, 2014 | -0.0164M |
| March 31, 2014 | -0.0123M |
| December 31, 2008 | -0.0394M |
| September 30, 2008 | -0.0561M |
| June 30, 2008 | -0.1297M |
| March 31, 2008 | -0.1764M |
| December 31, 2007 | -0.2243M |
| September 30, 2007 | -0.357M |
| June 30, 2007 | -0.3983M |
| March 31, 2007 | -0.1864M |
| December 31, 2006 | -0.1579M |
| September 30, 2006 | -0.2547M |
| June 30, 2006 | -0.3967M |
| March 31, 2006 | -0.2776M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Aibotics, Inc. | -0.537M |
| GeneDx Holdings Corp. | -17.74M |
| Ayujoy Herbals Ltd. | -- |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.1098M |
| Total Expenses (Quarterly) | 0.0707M |
| EPS Diluted (Quarterly) | 0.0002 |
| Enterprise Value | 2.620M |
| Profit Margin (Quarterly) | 35.61% |
| Earnings Yield | 3.81% |
| Operating Earnings Yield | 4.10% |
| Normalized Earnings Yield | 3.810 |